Argenica Therapeutics Share Price and Company Fundamentals



Price
$0.39
Change
0.005 (1.299%)
52 week
0.18 - 0.42

Last traded: Today at 6:10 AM

Argenica Therapeutics Limited researches and develops a neuroprotective therapeutic drug in Australia. The company's product is ARG-007, a neuroprotective peptide candidate for use in the protection of brain tissue against damage during a stroke and other acute central nervous system injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.

Key Metrics

PE ratio

-

PB ratio

4.15

Dividend yield

Beta

-

Market cap

$28.54M

Enterprise value

$21.03M

Company profile

Primary activitiesDevelopment and commercialisation of a novel therapeutic
Industry / SectorBiotechnology / Healthcare
Websitehttp://argenica.com.au
Mailing address117 Broadway Unit 4 Nedlands WA 6009 Australia
Phone / Fax61 8 9329 3396 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Argenica Therapeutics does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Argenica Therapeutics.

NameTitleAgeTotal Pay
Dr. Liz Dallimore B.Sc., M.B.A., Ph.D.Chief Exec. Officer
Ms. Emma WaldonCFO & Company Sec.44
Dr. Samantha South GAICD, MBA, Ph.D.COO & Exec. Director
Prof. Bruno Philip MeloniChief Scientific Officer

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-347.76%

Return on assets

-16.82%

Return on equity

-29.99%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Argenica Therapeutics is 28.54M and its enterprise value is 21.03M. The enterprise value to revenue ratio of AGN is 71.02.

Companies similar to Argenica Therapeutics (AGN)

Argenica Therapeutics (ASX:AGN) Frequently Asked Questions

1. What is Argenica Therapeutics's Stock Symbol?

Argenica Therapeutics trades on ASX under the ticker symbol "AGN".

2. What is Argenica Therapeutics's stock price today?

One share of AGN stock can currently be purchased for approximately $0.39.

3. How can I contact Argenica Therapeutics?

Argenica Therapeutics's mailing address is 117 Broadway Unit 4 Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 9329 3396.

4. What is Argenica Therapeutics's official website?

The official website of Argenica Therapeutics is http://argenica.com.au.

5. Which share registry manages Argenica Therapeutics's stock?

Argenica Therapeutics's stock is managed by LINK MARKET SERVICES LIMITED.